Prior cryopreservation of ex vivo-expanded cord blood cells is not detrimental to engraftment as measured in the NOD-SCID mouse model

被引:6
作者
Rice, AM [1 ]
Wood, JA
Milross, CG
Collins, CJ
Case, J
Nordon, RE
Vowels, MR
机构
[1] Univ New S Wales, Childrens Canc Inst Australia Med Res, Prince Wales Hosp, Randwick, NSW, Australia
[2] Univ New S Wales, Grad Sch Biomed Engn, Randwick, NSW, Australia
[3] Sydney Childrens Hosp, Div Haematol Oncol, Randwick, NSW, Australia
来源
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH | 2001年 / 10卷 / 01期
关键词
D O I
10.1089/152581601750098435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cytokine-mediated expansion has been proposed and successfully used to facilitate engraftment post transplantation. This study examined whether cryopreservation following expansion has a detrimental effect on the ability of cells to engraft, using the NOD- SCID mouse model. Cord blood (CB) CD34(+) cells were incubated for 7 days with stem cell factor (SCF), flt-3 ligand (FL), and megakaryocyte growth and development factor (MGDF). Expanded CD34(+) cells were transplanted into NOD-SCID mice either fresh or following cryopreservation and thawing. After thawing, recovery of nucleated cells was 94%, of CD34 cells was 63%, and of day-14 progenitors was 17%. The loss of day-14 progenitor cells among the thawed expanded cells did not influence the kinetics of human engraftment in the mouse. Bone marrow (BM) of mice transplanted with thawed expanded CD34(+) cells (14 +/- 3.9%) showed significantly higher levels of human engraftment than mice transplanted with fresh expanded CD34(+) cells (1.5 +/- 0.5%, p = 0.0064). Thawed expanded CD34(+) cells had significantly higher SCID Engrafting Potential (SEP) than freshly expanded CD34(+) cells (p < 0.001). Results suggest that prior cryopreservation does not prevent expanded cells engrafting in NOD-SCID mice.
引用
收藏
页码:157 / 165
页数:9
相关论文
共 25 条
[1]   Effects of long-term storage at -90°C of bone marrow and PBPC on cell recovery, viability, and clonogenic potential [J].
Ayello, J ;
Semidei-Pomales, M ;
Preti, R ;
Hesdorffer, C ;
Reiss, RF .
JOURNAL OF HEMATOTHERAPY, 1998, 7 (04) :385-390
[2]   Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice [J].
Bonnet, D ;
Bhatia, M ;
Wang, JCY ;
Kapp, U ;
Dick, JE .
BONE MARROW TRANSPLANTATION, 1999, 23 (03) :203-209
[3]  
Case J, 1996, J Hematother, V5, P255, DOI 10.1089/scd.1.1996.5.255
[4]  
Case J, 2001, CYTOMETRY, V43, P69, DOI 10.1002/1097-0320(20010101)43:1<69::AID-CYTO1020>3.3.CO
[5]  
2-X
[6]  
Case J, 1998, EXP HEMATOL, V26, P699
[7]   FLT3 ligand preserves the ability of human CD34(+) progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction [J].
Dao, MA ;
Hannum, CH ;
Kohn, DB ;
Nolta, JA .
BLOOD, 1997, 89 (02) :446-456
[8]   A SIMPLIFIED METHOD FOR CRYOPRESERVATION OF HEMATOPOIETIC STEM-CELLS WITH -80-DEGREES-C MECHANICAL FREEZER WITH DIMETHYL-SULFOXIDE AS THE SOLE CRYOPROTECTANT [J].
GALMES, A ;
BESALDUCH, J ;
BARGAY, J ;
MATAMOROS, N ;
MOREY, M ;
NOVO, A ;
SAMPOL, A .
LEUKEMIA & LYMPHOMA, 1995, 17 (1-2) :181-184
[9]   Cell culture bags allow a large extent of ex vivo expansion of LTC-IC and functional mature cells which can subsequently be frozen:: interest for large-scale clinical applications [J].
Giarratana, MC ;
Kobari, L ;
Nguyen, TMAN ;
Firat, H ;
Bouchet, S ;
Lopez, M ;
Gorin, NC ;
Thierry, D ;
Douay, L .
BONE MARROW TRANSPLANTATION, 1998, 22 (07) :707-715
[10]   Outcome of cord-blood transplantation from related and unrelated donors [J].
Gluckman, E ;
Rocha, V ;
BoyerChammard, A ;
Locatelli, F ;
Arcese, W ;
Pasquini, R ;
Ortega, J ;
Souillet, G ;
Ferreira, E ;
Laporte, JP ;
Fernandez, M ;
Chastang, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :373-381